Cargando…

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to widespread use of hydroxychloroquine and azithromycin despite the lack of conclusive evidence for their safety and efficacy. We evaluated the association between treatment with hydroxychloroquine and/or azithromycin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albani, Filippo, Fusina, Federica, Giovannini, Alessia, Ferretti, Pierluigi, Granato, Anna, Prezioso, Chiara, Divizia, Danilo, Sabaini, Alessandra, Marri, Marco, Malpetti, Elena, Natalini, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563535/ https://www.ncbi.nlm.nih.gov/pubmed/32872629 http://dx.doi.org/10.3390/jcm9092800

Ejemplares similares

Central venous pressure and dynamic indices to assess fluid appropriateness in critically ill patients: A pilot study
por: Prezioso, Chiara, et al.
Publicado: (2023)

Early percutaneous tracheotomy in coronavirus disease 2019 (COVID-19) and infection in healthcare personnel: a cohort study
por: Rosano, Antonio, et al.
Publicado: (2021)

Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients
por: Albani, Filippo, et al.
Publicado: (2021)

Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study
por: Albani, Filippo, et al.
Publicado: (2020)

Flow Index accurately identifies breaths with low or high inspiratory effort during pressure support ventilation
por: Albani, Filippo, et al.
Publicado: (2021)

Respiratory system compliance at the same PEEP level is similar in COVID and non-COVID ARDS
por: Fusina, Federica, et al.
Publicado: (2022)

Flow Index: a novel, non-invasive, continuous, quantitative method to evaluate patient inspiratory effort during pressure support ventilation
por: Albani, Filippo, et al.
Publicado: (2021)

Antibody Response after BNT162b2 Vaccination in Healthcare Workers Previously Exposed and Not Exposed to SARS-CoV-2
por: Salvaggio, Marcello, et al.
Publicado: (2021)

Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?
por: Lemmers, Daniel H.L., et al.
Publicado: (2020)

Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19
por: Lauriola, Marinella, et al.
Publicado: (2020)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
por: Fiolet, Thibault, et al.
Publicado: (2021)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
por: Derendorf, Hartmut
Publicado: (2020)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response
por: Fiolet, Thibault, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Anticoagulants/azithromycin/hydroxychloroquine: Spontaneous haematoma: case report
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Azithromycin/ceftriaxone/hydroxychloroquine: Acute urticaria: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: SDRIFE-like rash: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Lack of efficacy: 2 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine/methylprednisolone: Various toxicities: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Various toxicities: 4 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine/methylprednisolone: Various toxicities: case report
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Lacout, Alexis, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
por: Arshad, Samia, et al.
Publicado: (2020)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Amphotericin-b-liposomal/azithromycin/hydroxychloroquine: No response: case report
Publicado: (2021)

Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
por: Xu, Jiuyang, et al.
Publicado: (2022)

Azithromycin/hydroxychloroquine/oseltamivir: Erythema multiforme major: case report
Publicado: (2021)

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
por: EL Ouarradi, Amal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_shlqgbndnt8rblrh47nop9mudn